| Periods | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 3 Years | All Time |
|---|---|---|---|---|---|---|---|
| Primex-40 | |||||||
| The Bormah Jan Tea Company 1936 Limited |
|
Particulars |
31-03-2025 |
31-03-2024 |
|
Non-current
Assets |
|
|
|
Property, Plant And Equipment |
3,33,331.26 |
3,34,912.57 |
|
Capital Work in Progress |
49,176.03 |
32,214.95 |
|
Investments |
83.55 |
83.55 |
|
Other Non-Current Financial Assets |
3,820.99 |
3,820.99 |
|
Other Non-Current Assets |
21,549.98 |
17,733.52 |
|
Deferred Tax Assets (Net) |
1,375.06 |
- |
|
Current
Assets |
|
|
|
Inventories |
54,539.88 |
46,454.11 |
|
Biological Assets Other Than Bearer Plants |
59,935.13 |
59,702.25 |
|
Trade Receivables |
646.67 |
- |
|
Cash And Cash Equivalents |
1,398.76 |
375.75 |
|
Other Bank Balances |
18.92 |
18.92 |
|
Other Financial Assets |
60.10 |
60.10 |
|
Current Tax Assets (Net) |
13,034.13 |
20,820.90 |
|
Other Current Assets |
13,119.69 |
9,940.00 |
|
Total Assets |
5,52,090.14 |
5,26,137.59 |
|
Equity |
|
|
|
Equity Share Capital |
1,250 |
1,250 |
|
Reserve & Surplus |
1,48,753.94 |
1,48,425.37 |
|
Non-Current Liabilities |
|
|
|
Borrowings |
10,078.85 |
7,753.33 |
|
Deferred
Tax Liabilities (Net) |
- |
368.65 |
|
Current Liabilities |
|
|
|
Borrowings |
2,29,273.49 |
2,33,545.61 |
|
Trade
Payables |
44,490.37 |
43,252.78 |
|
Other Current
Liabilities |
1,18,243.50 |
91,541.85 |
|
Total equity and liabilities |
5,52,090.14 |
5,26,137.59 |
|
Particulars |
31-03-2025 |
31-03-2024 |
|
INCOME |
|
|
|
Revenue From Operations |
3,47,381.04 |
3,02,929.23 |
|
Other Income |
5,600.33 |
5,730.11 |
|
Total Revenue |
3,52,981.37 |
3,08,659.34 |
|
EXPENSES |
|
|
|
Change in Inventories of Finished Goods |
-8,206.73 |
-3,972.32 |
|
Change in Value of Biological Assets |
-232.89 |
-8,790.73 |
|
Employees Benefits Expenses |
2,49,893.24 |
2,36,907.01 |
|
Finance Costs |
20,447.72 |
19,645.18 |
|
Depreciation & Amortisation Expenses |
12,763.95 |
13,068.84 |
|
Other Expenses |
75,711.34 |
79,759.69 |
|
Total Expenses |
3,50,376.64 |
3,36,617.66 |
|
Profit / Loss Before Tax |
2,604.74 |
-27,958.32 |
|
Income Tax / Agriculture Income Tax - Current |
1,851.85 |
- |
|
Income Tax For Earlier Years |
1,430.72 |
- |
|
Deferred Tax |
-1,006.41 |
-1,506.40 |
|
Profit / Loss For The Year |
328.57 |
-26,451.92 |
|
Earnings
Per Equity Share |
|
|
|
Basic & Diluted |
2.63 |
-211.62 |
|
Particulars |
31-03-2025 |
31-03-2024 |
|
Cash Flow From Operating Activities |
|
|
|
Net Profit Before Taxation |
2,604.74 |
-27,958.32 |
|
Adjustments
For: |
|
|
|
Depreciation And Amortisation Expenses |
12,763.95 |
13,068.84 |
|
Finance Costs |
20,447.72 |
19,645.18 |
|
Interest Income |
-5,195.39 |
-96.42 |
|
Profit/(Loss) on Disposal of Property, Plant
& Equipments |
-404.95 |
|
|
Change in Fair Value of Biological Assets |
-232 89 |
-8,790.7 |
|
Operating Profit Before Working Capital Changes |
29,983.18 |
-4,131.45 |
|
Changes in Working Capital: |
|
|
|
Adjustments For (Increase Decrease in
Operating Assets |
|
|
|
Trade Receivables, Other Financial Assets |
-646.67 |
132.75 |
|
Loans And Advances |
-479.29 |
-2,412.81 |
|
Inventories |
-8,206.73 |
-3,972.32 |
|
Adjustment For Increase (Decrease) in
Operating Liabilities |
|
|
|
Trade Payables |
24,812.68 |
25,335.11 |
|
Other Financial Liabilities |
- |
- |
|
Cash
Generated From Operating Activities |
45,463.17 |
14,951.27 |
|
Direct Taxes Paid |
3,866.43 |
-3,781.14 |
|
Net Cash Flow From Operating Activities |
49,329.60 |
11,170.14 |
|
Cash Flow From Investing Activities |
|
|
|
Purchases of Property, Plant & Equipments |
-32,095.77 |
-18,770.58 |
|
Interest Income |
5,195.39 |
96.42 |
|
Sale/ Insurance Claim of Property, Plant &
Equipments |
404.95 |
- |
|
Net Cash Used in Investing Activities |
22,834.16 |
-7,504.02 |
|
Cash Flow From Financing Activities |
|
|
|
Proceeds From Short Term Borrowings |
-4,272.12 |
31,187.96 |
|
Proceeds From Long Term Borrowings |
2,325.52 |
-7,755,01 |
|
Finance Costs |
-19,864
55 |
-16,148.04 |
|
Dividend Paid |
- |
-20.67 |
|
Net Cash Used in Financing Activities |
-21,811.16 |
7,264.24 |
|
Net Increase/(Decrease) in Cash And Cash
Equivalents |
1,023.01 |
-239.77 |
|
Cash
& Cash Equivalents (Opening Balance) |
394.66 |
634.44 |
|
Cash & Cash Equivalents (Closing
Balance) |
1,417.67 |
394.66 |
Summary
of cash flow statement for the year 2025 and 2024:
Cash Flow from Operating Activities:
The company reported a strong improvement in operating performance during 2025.
Net profit before tax turned positive at ₹2,604.74 thousand compared to a
significant loss of ₹27,958.32 thousand in 2024. After adjusting for non-cash
and financial items such as depreciation, finance costs, and interest income,
operating profit before working capital changes rose to ₹29,983.18 thousand
from a negative ₹4,131.45 thousand. Working capital changes showed mixed
trends—inventory and loans increased (indicating higher investment), while
trade payables rose substantially, supporting cash inflows. Overall, cash
generated from operations increased significantly to ₹45,463.17 thousand. After
accounting for taxes, net cash flow from operating activities stood at
₹49,329.60 thousand, reflecting strong operational recovery and improved
cash-generating ability.
Cash Flow from Investing Activities:
The company continued to invest heavily in fixed assets, with purchases of
property, plant, and equipment increasing to ₹32,095.77 thousand in 2025 from
₹18,770.58 thousand in 2024. However, inflows from interest income and sale of
assets provided partial support. Despite these inflows, the company recorded a
net cash outflow from investing activities (₹22,834.16 thousand), indicating
ongoing capital expenditure aimed at expansion or modernization. This suggests
a long-term growth strategy, although it places pressure on short-term cash
resources.
Cash Flow from Financing Activities:
Financing activities showed a net cash outflow of ₹21,811.16 thousand in 2025,
compared to an inflow of ₹7,264.24 thousand in 2024. The company reduced its
reliance on short-term borrowings and had only a modest increase in long-term
borrowings. At the same time, finance costs remained high, leading to
significant cash outflows. Unlike the previous year, no dividend was paid.
Overall, the company appears to be deleveraging and servicing its debt
obligations, which is a positive sign for financial stability but reduces
available cash.
Net Change in Cash and Cash Equivalents:
The combined effect of strong operating inflows and significant investing and
financing outflows resulted in a net increase in cash of ₹1,023.01 thousand in
2025, compared to a decrease of ₹239.77 thousand in 2024. This indicates an
overall improvement in liquidity position.
|
Particulars |
31-03-2025 |
31-03-2024 |
|
Current Ratio |
0.36 |
0.37 |
|
Debt - Equity Ratio |
1.59 |
1.61 |
|
Debt Service Coverage Ratio |
1.75 |
0.24 |
|
Return on Equity |
0.01 |
-16.24 |
|
Inventory Turnover Ratio |
6.74 |
1.78 |
|
Trade Receivables Turnover Ratio |
1,074.36 |
4,674.91 |
|
Net Capital Turnover Ratio |
-1.41 |
-1.31 |
|
Net Profit Ratio |
0.001 |
-8.73 |
|
Return on Capital Employed |
0.16 |
-2.12 |
Summary of financial ratios for the year 2025 and 2024:
Current Ratio:
The current ratio declined slightly from 0.37 in 2024 to 0.36 in 2025,
remaining well below the ideal benchmark of 1. This indicates that the company continues
to face liquidity constraints and may struggle to meet its short-term
obligations using current assets. The marginal decline suggests no significant
improvement in working capital management.
Debt-Equity Ratio:
The debt-equity ratio decreased slightly from 1.61 to 1.59, indicating a
marginal reduction in financial leverage. However, the ratio still reflects a
relatively high dependence on debt financing compared to equity, which could
pose long-term financial risk if not managed carefully.
Debt Service Coverage Ratio:
The DSCR improved significantly from 0.24 in 2024 to 1.75 in 2025. This
indicates a strong turnaround in the company’s ability to service its debt
obligations from operating income. A DSCR above 1 suggests that the company is
now generating sufficient earnings to cover its debt repayments.
Return on Equity:
ROE improved drastically from -16.24% in 2024 to 0.01% in 2025. While the
company has moved from heavy losses to near break-even returns for shareholders,
the profitability remains extremely low, indicating that equity capital is not
yet being effectively utilized to generate returns.
Inventory Turnover Ratio:
The inventory turnover ratio increased significantly from 1.78 to 6.74,
indicating a major improvement in inventory management. The company is now able
to sell and replace its inventory much faster, which reflects better
operational efficiency and possibly improved demand or sales performance.
Trade Receivables Turnover Ratio:
This ratio dropped sharply from 4,674.91 to 1,074.36. Although still very high,
the decline suggests that the company is taking relatively longer to collect
receivables compared to the previous year. This could indicate a relaxation in
credit policy or slower collections.
Net Capital Turnover Ratio:
The ratio worsened slightly from -1.31 to -1.41, remaining negative in both
years. This indicates inefficient use of working capital, where sales are not
being effectively generated relative to net capital employed. The negative
value reflects underlying operational or structural inefficiencies.
Net Profit Ratio:
The net profit ratio improved significantly from -8.73% to 0.001%, indicating a
shift from losses to marginal profitability. However, the profit margin remains
negligible, suggesting that the company still faces challenges in controlling
costs or improving revenue generation.
Return on Capital Employed:
ROCE improved from -2.12% to 0.16%, showing a transition from negative to
slightly positive returns on total capital employed. While this reflects an
improvement in overall efficiency, the returns are still very low and indicate
limited effectiveness in utilizing capital resources.